Abstract
The expression of lymphotoxin (LT) mRNA and cytokine in human tonsillar B cells and B cell lines was examined by Northern blots and cytotoxicity assays, respectively. In tonsillar B cells, phorbol myristate acetate (PMA) or Staphylococcus aureus Cowan l (SAC) alone induced low levels of LT mRNA accumulation. However, SAC and anti-mu were strongly synergistic with PMA in this induction. Peak LT mRNA expression in tonsillar B cells stimulated by PMA plus SAC occurred between 48 and 72 h and was approximately half as much as that in PMA plus anti-CD3-stimulated T cells. Cyclosporine A was not effective in inhibiting LT mRNA accumulation by stimulated tonsillar B cells. A number of B cell lines could also be stimulated by PMA to express LT mRNA. Peak accumulation of LT mRNA in the cell line RPMI 1788 stimulated with PMA peaked about 8 h. A23187 in combination with PMA caused this accumulation to increase slightly and to peak earlier. The cytotoxic effects in the supernatants of stimulated B cells were contributed mostly by LT. The results indicate that tonsillar B cells are important in LT production and that there are important differences in the stimulation requirements for LT production and in LT mRNA expression kinetics between tonsillar B cells and B cell lines.
MeSH Terms
B-Lymphocytes/metabolism
Blotting, Northern
Cell Line
Cytotoxicity Tests, Immunologic
Electrophoresis, Agar Gel
Gene Expression Regulation
Humans
Lymphotoxin-alpha/biosynthesis
Palatine Tonsil/metabolism
RNA, Messenger/genetics
Tetradecanoylphorbol Acetate/pharmacology
Tumor Necrosis Factor-alpha/metabolism
Chemicals
Lymphotoxin-alpha
RNA, Messenger
Tumor Necrosis Factor-alpha
Tetradecanoylphorbol Acetate
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Sung S S
Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City 73104.
Jung L K
Walters J A
Jeffes E W
Granger G A
Fu S M
References (27)
27 references, click to expand
-
Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity.
Science. 1967 Sep 1;157(3792):1060-2
PMID: 6036235
-
T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.
Mol Cell Biol. 1987 Dec;7(12):4472-81
PMID: 2830495
-
Lymphotoxin detected in the blister fluid of bullous pemphigoid patients.
J Clin Immunol. 1984 Jan;4(1):31-5
PMID: 6365950
-
Production of interleukin 1 activity by normal human peripheral blood B lymphocytes.
J Immunol. 1985 Aug;135(2):1132-6
PMID: 3874231
-
Lymphotoxins, macrophage cytotoxins, and tumor necrosis factors: an interrelated family of antitumor effector molecules.
J Clin Immunol. 1985 Jul;5(4):217-9
PMID: 3876351
-
The effects of cyclosporin A on the immune system.
Annu Rev Immunol. 1985;3:397-423
PMID: 3933532
-
The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.
J Exp Med. 1988 Feb 1;167(2):332-44
PMID: 3258006
-
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.
Nature. 1988 Mar 3;332(6159):83-5
PMID: 3258060
-
Tumour necrosis factor beta (lymphotoxin) inhibits locomotion and stimulates the respiratory burst and degranulation of neutrophils.
Immunology. 1988 Mar;63(3):507-12
PMID: 2832316
-
The common mediator of shock, cachexia, and tumor necrosis.
Adv Immunol. 1988;42:213-31
PMID: 2834923
-
Lymphotoxin.
Annu Rev Immunol. 1988;6:407-38
PMID: 3289572
-
The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.
J Immunol. 1988 Jul 15;141(2):499-503
PMID: 2968403
-
Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell.
Transplantation. 1988 Aug;46(2 Suppl):53S-60S
PMID: 3136567
-
Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.
J Exp Med. 1988 Nov 1;168(5):1539-51
PMID: 3263462
-
Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
J Immunol. 1986 May 15;136(10):3636-42
PMID: 3009608
-
The role of the T3/antigen receptor complex in T-cell activation.
Annu Rev Immunol. 1986;4:593-619
PMID: 2939858
-
Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.
Nature. 1986 Oct 30-Nov 5;323(6091):819-22
PMID: 2430188
-
Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome.
Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:611-24
PMID: 3555974
-
Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
J Immunol. 1987 Jun 15;138(12):4298-302
PMID: 3495589
-
Molecular mechanisms of transmembrane signaling in B lymphocytes.
Annu Rev Immunol. 1987;5:175-99
PMID: 2439102
-
Cytotoxic effector function of B lymphoblasts.
J Immunol. 1987 Jul 15;139(2):645-8
PMID: 3496385
-
Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin.
J Clin Immunol. 1987 Jul;7(4):333-40
PMID: 3611300
-
Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells.
N Engl J Med. 1987 Aug 27;317(9):526-32
PMID: 3497347
-
Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells.
J Immunol. 1987 Sep 15;139(6):1891-5
PMID: 3497981
-
Effect of tumor necrosis factor alpha on mitogen-activated human B cells.
J Exp Med. 1987 Sep 1;166(3):786-91
PMID: 3040886
-
Lymphotoxin is an important T cell-derived growth factor for human B cells.
Science. 1987 Nov 20;238(4830):1144-6
PMID: 3500512
-
Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor.
Nature. 1968 Jun 29;218(5148):1253-4
PMID: 5656652